BRCA Biomarkers
News and reporting on BRCA biomarkers.
Genetic Testing Challenges in Oncology: BRCA1-Positive Patient Told Paternal Cancer Risk Unimportant
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
Tango Therapeutics to Go Public on Nasdaq Through SPAC
The combined company is expected to receive $353 million in gross proceeds, which will help advance several of Tango's precision oncology drug candidates.
Genetic Testing Challenges in Oncology: BRCA1-Positive Breast Cancer Patient Told She's Negative
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
In Brief This Week: Merck, Clovis Oncology, Grail, GenomOncology, Veracyte, Amoy Diagnostics
News items for the week of March 15, 2021.Â
UK's NICE Does Not Recommend Lynparza for BRCA-Mutated Prostate Cancer
Lynparza is already approved to treat metastatic prostate cancer with BRCA1/2 mutations in Europe and the US.